Notice: This company has been marked as potentially delisted and may not be actively trading. Otonomy (OTIC) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Otonomy, Inc. (OTIC) Stock Historical Prices & Data - Yahoo FinanceJanuary 23, 2023 | finance.yahoo.comOtonomy, Inc.: Otonomy Provides Corporate UpdateDecember 21, 2022 | finanznachrichten.deOtonomy Provides Corporate UpdateDecember 19, 2022 | finance.yahoo.comTrading was temporarily halted for "OTIC" at 04:12 PM with a stated reason of "News pending."December 19, 2022 | marketbeat.com5 Investors Betting Big on Otonomy (OTIC) StockNovember 30, 2022 | investorplace.comWhy Is Otonomy (OTIC) Stock Up 97% Today?November 29, 2022 | investorplace.comOtonomy Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 10, 2022 | finance.yahoo.comOTIC.OQ - Otonomy Inc | Stock Price & Latest News | ReutersNovember 6, 2022 | reuters.comOTONOMY, INC. : Results of Operations and Financial Condition (form 8-K) - Marketscreener.comOctober 14, 2022 | marketscreener.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.83% By Investing.com - Investing.comOctober 13, 2022 | investing.comLianBio To Shut BridgeBio-Partnered Bile Duct Cancer Drug Trial - Yahoo FinanceOctober 13, 2022 | finance.yahoo.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.83% - StreetInsider.comOctober 13, 2022 | streetinsider.comOtonomy shares are trading lower after the company reported higher dose cohorts for OTO-413 demonstrated no clinically meaningful improvement for patients from baseline. - Otonomy (NASDAQ:OTIC) - BenzingaOctober 13, 2022 | benzinga.comOtonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss -- Shares Nosedive - Marketscreener.comOctober 13, 2022 | marketscreener.comWhy Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday’s Mid- - BenzingaOctober 13, 2022 | benzinga.comOtonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss - Marketscreener.comOctober 13, 2022 | marketscreener.comOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss - GlobeNewswireOctober 13, 2022 | globenewswire.comOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss - Yahoo FinanceOctober 13, 2022 | finance.yahoo.comOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing LossOctober 13, 2022 | finance.yahoo.comOTIC.O - Otonomy Inc | Stock Price & Latest News | ReutersOctober 7, 2022 | reuters.comAPPLIED GENETIC TECHNOLOGIES CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.comSeptember 27, 2022 | marketscreener.comOTONOMY, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.comSeptember 17, 2022 | marketscreener.comForm SC 13G/A OTONOMY, INC. Filed by: FEDERATED HERMES, INC. - StreetInsider.comSeptember 9, 2022 | streetinsider.comAGTC to Participate in Upcoming Investor Conferences - Yahoo FinanceSeptember 1, 2022 | finance.yahoo.comOtonomy : Costs Associated with Exit or Disposal Activities - Form 8-K - Marketscreener.comAugust 11, 2022 | marketscreener.comOTONOMY, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers (form 8-K) - Marketscreener.comAugust 9, 2022 | marketscreener.comShort Volatility Alert: Otonomy, Inc. - BenzingaAugust 6, 2022 | benzinga.comThis Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving PremarketAugust 3, 2022 | benzinga.comOTIC stock downgraded at H.C. Wainwright as tinnitus candidate fails (NASDAQ:OTIC) - Seeking AlphaAugust 2, 2022 | seekingalpha.comHC Wainwright Downgrades Otonomy to Neutral From Buy - Marketscreener.comAugust 2, 2022 | marketscreener.comDaily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial By Benzinga - Investing.com UKAugust 2, 2022 | uk.investing.comOtonomy Shares Plumb New Depths on Failure of Lead Program >OTIC - MarketWatchAugust 2, 2022 | marketwatch.comAGTC to Participate in Upcomin - GuruFocus.comAugust 1, 2022 | gurufocus.comPiper Sandler Adjusts Otonomy Price Target to $3 From $6, Maintains Overweight Rating - Marketscreener.comAugust 1, 2022 | marketscreener.comVirax, Aethlon top healthcare gainers; while Otonomy, Kazia lead losers' pack - Seeking AlphaAugust 1, 2022 | seekingalpha.comOtonomy Shares Sink After Stopping Mid-Stage Tinnitus StudyAugust 1, 2022 | finance.yahoo.comOtonomy Reports Results From Phase 2 Clinical Trial Of OTO-313 In Patients With Tinnitus; Co. Reports 'OT - BenzingaAugust 1, 2022 | benzinga.comOtonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus - GlobeNewswireAugust 1, 2022 | globenewswire.comOtonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with TinnitusAugust 1, 2022 | finance.yahoo.comTrading was temporarily halted for "OTIC" at 07:08 AM with a stated reason of "News pending."August 1, 2022 | marketbeat.comOtonomy (NASDAQ:OTIC) Research Coverage Started at StockNews.comJuly 30, 2022 | americanbankingnews.comWalmart Cuts Q2, FY Profit Outlook; Stock Down - NasdaqJuly 27, 2022 | nasdaq.comTwo Clinical Studies to Treat Mild-to-Moderate COVID-19 at Home Reveal Value of Exscalate, Dompé's AI Platform for Drug Design - Yahoo FinanceJuly 27, 2022 | finance.yahoo.comOtonomy shares are trading lower after the company reported Q2 earnings results. - Benzinga - BenzingaJuly 26, 2022 | benzinga.comAGTC Receives Positive Type C Meeting Feedback from the FDA for the Company's Design and Operating Procedures of its Planned cGMP Manufacturing Facility - Marketscreener.comJuly 26, 2022 | marketscreener.comHealthStream EPS Tops Estimate, MEDP Revises Forecast, OTIC To Report Tinnitus Trial Data In August - RTTNewsJuly 26, 2022 | rttnews.comOtonomy (NASDAQ:OTIC) Announces Quarterly Earnings ResultsOtonomy (NASDAQ:OTIC - Get Rating) announced its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.20) by $0.01. During the same quarter in the previous year, the company posted ($0.19) EPS.July 26, 2022 | marketbeat.comOtonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update - GlobeNewswireJuly 26, 2022 | globenewswire.comOtonomy Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateJuly 25, 2022 | finance.yahoo.comOtonomy's Earnings Outlook - Benzinga - BenzingaJuly 22, 2022 | benzinga.com Get Otonomy News Delivered to You Automatically Sign up to receive the latest news and ratings for OTIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide OTIC Media Mentions By Week OTIC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OTIC News Sentiment▼-0.240.46▲Average Medical News Sentiment OTIC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OTIC Articles This Week▼00▲OTIC Articles Average Week Get Otonomy News Delivered to You Automatically Sign up to receive the latest news and ratings for OTIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CMND News Today NTBL News Today GRTX News Today SXTP News Today SLRX News Today BPTH News Today SONN News Today GRI News Today GLMD News Today PRFX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OTIC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Otonomy, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Otonomy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.